You have no items in your shopping cart.
BTK inhibitor 20
SKU: orb1744755
Description
Research Area
Cardiovascular Research, Pharmacology & Drug Discovery; Cell Biology, Signal Transduction
Images & Validation
−
Key Properties
−| CAS Number | 2696450-27-6 |
|---|---|
| MW | 662.78 |
| Formula | C37H42N8O4 |
| SMILES | O=C1C=2N(C3=C(C2)CC(C)(C)C3)C=CN1C4=C(CO)C(=CC=N4)C=5C=C(NC6=CC=C(C=N6)N7[C@@H](C)CN(CC7)C8COC8)C(=O)N(C)C5 |
| Target | Others,BTK |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Olmutinib [orb1300347]
99.63% (May vary between batches)
1353550-13-6
486.59
C26H26N6O2S
2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 1 ml x 10 mM (in DMSO)Sunvozertinib [orb1685916]
99.71% (May vary between batches)
2370013-12-8
584.08
C29H35ClFN7O3
25 mg, 50 mg, 100 mg, 1 mg, 5 mg, 10 mg, 500 mg, 1 ml x 10 mM (in DMSO)(S)-Sunvozertinib [orb1298200]
99.69% (May vary between batches)
2370013-49-1
584.08
C29H35ClFN7O3
50 mg, 100 mg, 1 mg, 5 mg, 10 mg, 25 mg, 1 ml x 10 mM (in DMSO)BMS-986142 [orb1226002]
>98% (HPLC)
1643368-58-4
572.613
C32H30F2N4O4
10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 5 mgPCI-29732 [orb1225284]
>98% (HPLC)
330786-25-9
371.435
C22H21N5O
2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.